T1	Nutrient 0 9	Prebiotic
T2	AFFECTS 10 16	effect
T3	Nutrient 20 40	inulin-type fructans
T4	Metabolite 66 89	short-chain fatty acids
T5	Disease 93 108	type 2 diabetes
T6	Methodology 112 139	randomised controlled trial
T7	Disease 205 220	type 2 diabetes
T8	Physiology 281 299	glucose regulation
T9	AFFECTS 353 359	effect
T10	Nutrient 363 383	inulin-type fructans
T11	Metabolite 413 436	short-chain fatty acids
T12	Metabolite 438 442	SCFA
T13	Population 447 476	patients with type 2 diabetes
T14	Disease 461 476	type 2 diabetes
T15	Methodology 502 536	placebo controlled crossover study
T17	Nutrient 599 619	inulin-type fructans
T18	Nutrient 634 647	oligofructose
T19	Nutrient 652 658	inulin
T20	Nutrient 678 690	maltodextrin
T21	Methodology 814 858	high-throughput 16S rRNA amplicon sequencing
T22	Metabolite 863 867	SCFA
T23	Biospecimen 871 877	faeces
T24	Methodology 898 917	vacuum distillation
T25	Methodology 930 948	gas chromatography
T26	Nutrient 973 993	inulin-type fructans
T27	Physiology 1077 1095	bifidogenic effect
T28	Microorganism 1186 1214	Bifidobacterium adolescentis
T29	Microorganism 1236 1247	Bacteroides
T30	AFFECTS 1129 1144	positive effect
T31	Metabolite 1295 1305	total SCFA
T32	Metabolite 1307 1318	acetic acid
T33	Metabolite 1323 1337	propionic acid
T34	Nutrient 1358 1367	prebiotic
T35	INCREASES 1263 1269	higher
T36	Nutrient 1405 1420	prebiotic fibre
T37	AFFECTS 1425 1435	no effects
T38	Metabolite 1460 1472	butyric acid
T39	Nutrient 1554 1574	inulin-type fructans
T40	Physiology 1593 1611	bifidogenic effect
T41	INCREASES 1624 1633	increased
T42	Metabolite 1652 1663	faecal SCFA
T43	Nutrient 1755 1775	inulin-type fructans
T44	INCREASES 1821 1829	increase
T45	Physiology 1830 1852	microbial fermentation
T46	Disease 1856 1871	type 2 diabetes
E1	AFFECTS:T2 Agent:T3 Theme:T4
E2	AFFECTS:T9 Agent:T10 Theme:T11
E3	AFFECTS:T30 Agent:T26 Theme:T28
E4	AFFECTS:T30 Agent:T26 Theme:T29
E5	INCREASES:T35 Agent:T34 Theme:T31
E6	INCREASES:T35 Agent:T34 Theme:T32
E7	INCREASES:T35 Agent:T34 Theme:T33
E8	AFFECTS:T37 Agent:T36 Theme:T38
E9	INCREASES:T41 Agent:T39 Theme:T42
E10	INCREASES:T44 Agent:T43 Theme:T45
A1	Factuality E1 Unknown
A2	Factuality E2 Unknown
A3	Factuality E8 Negated
N1	Reference T1 MESH:D056692	Prebiotics
N2	Reference T4 CHEBI:26666	short-chain fatty acid
N3	Reference T5 NCIT:C26747	Type 2 Diabetes Mellitus
N4	Reference T7 NCIT:C26747	Type 2 Diabetes Mellitus
N5	Reference T11 CHEBI:26666	short-chain fatty acid
N6	Reference T12 CHEBI:26666	short-chain fatty acid
N7	Reference T14 NCIT:C26747	Type 2 Diabetes Mellitus
N8	Reference T18 MESH:C120489	oligofructose
N9	Reference T19 CHEBI:15443	inulin
N10	Reference T20 CHEBI:25140	maltodextrin
N11	Reference T22 CHEBI:26666	short-chain fatty acid
N12	Reference T28 NCBITAXON:1680	Bifidobacterium adolescentis
N13	Reference T29 NCBITAXON:816	Bacteroides
N14	Reference T31 CHEBI:26666	short-chain fatty acid
N15	Reference T32 CHEBI:15366	acetic acid
N16	Reference T33 CHEBI:30768	propionic acid
N17	Reference T34 MESH:D056692	Prebiotics
N18	Reference T36 NCIT:C68492	Dietary Fiber
N19	Reference T38 CHEBI:30772	butyric acid
N20	Reference T42 CHEBI:26666	short-chain fatty acid
N21	Reference T46 NCIT:C26747	Type 2 Diabetes Mellitus
